SinoMab BioScience Limited (3681.HK)
HKD 1.03
(-1.9%)
HKD 1.03
(-1.9%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.36 Million | 4.03 Million | 26.65 Million | 12.76 Million | - | 1.48 Million |
| Cost of Revenue | 943 Thousand | - | - | - | - | - |
| Gross Profit | 422 Thousand | 4.03 Million | 26.65 Million | 12.76 Million | - | 1.48 Million |
| Operating Expenses | 422 Thousand | 292.81 Million | 325.76 Million | 150.29 Million | 275.88 Million | 54.79 Million |
| Selling, General and Administrative Expenses | 97.61 Million | 82.59 Million | 133.4 Million | 72.01 Million | 61.54 Million | 2.01 Million |
| Research and Development Expenses | 135.4 Million | 180.36 Million | 199.11 Million | 103.4 Million | 214.34 Million | 47.28 Million |
| Other Expenses | - | - | -180 Thousand | - | -77 Thousand | -617 Thousand |
| Cost and Expenses | 230.94 Million | 292.81 Million | 325.76 Million | 150.29 Million | 275.88 Million | 54.79 Million |
| Operating Income | -229.57 Million | -258.92 Million | -305.85 Million | -162.65 Million | -273.94 Million | -54.79 Million |
| Interest Expense | 6.58 Million | - | 5.82 Million | - | 2.33 Million | 3.03 Million |
| Income Tax Expense | - | - | 9.19 Million | - | 2.33 Million | -25.78 Million |
| Earnings before Tax | -243.11 Million | -284.15 Million | -288.19 Million | -122.6 Million | -276.28 Million | -83.61 Million |
| Net Income | -243.11 Million | -284.15 Million | -288.19 Million | -122.6 Million | -278.62 Million | -83.61 Million |
| Earnings Per Share Basic | -0.24 | -0.29 | -0.29 | -0.12 | -0.33 | -0.08 |
| Earnings Per Share Diluted | -0.24 | -0.29 | -0.29 | -0.12 | -0.33 | -0.08 |
| Weighted Average Shares Outstanding | 1.01 Billion | 991.95 Million | 994.88 Million | 1 Billion | 836.65 Million | 1 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.01 Billion | 991.95 Million | 994.88 Million | 1 Billion | 836.65 Million | 1 Billion |
| Gross Margin | 0.31 | 1.00 | 1.00 | 1.00 | - | 1.00 |
| EBIT Margin | -146.86 | -60.59 | -11.12 | -12.43 | - | -54.36 |
| Profit Margin | -178.10 | -70.48 | -10.81 | -9.61 | - | -56.49 |
| EBITDA | -200.46 Million | -244.29 Million | -296.42 Million | -158.61 Million | -273.65 Million | -80.44 Million |
| Earnings Before Tax Margin | -168.19 | -64.22 | -11.47 | -12.75 | - | -37.03 |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 6.08 Million | -4.07 Million | 1.36 Million | 8.46 Million | 4.03 Million | -3.42 Million |
| Cost of Revenue | 1.48 Million | - | 943 Thousand | 943 Thousand | - | - |
| Gross Profit | 4.59 Million | -4.07 Million | 422 Thousand | 7.52 Million | 4.03 Million | -3.42 Million |
| Operating Expenses | 89.24 Million | 116.07 Million | 229.99 Million | 138.42 Million | 292.81 Million | 143.7 Million |
| Selling, General and Administrative Expenses | 34.2 Million | 47.41 Million | - | 50.2 Million | - | 48.74 Million |
| Research and Development Expenses | 55.03 Million | 68.65 Million | - | 66.75 Million | - | 98.23 Million |
| Other Expenses | - | - | 1.22 Million | - | - | - |
| Cost and Expenses | 90.72 Million | 116.07 Million | 230.94 Million | 139.36 Million | 292.81 Million | 143.7 Million |
| Operating Income | -84.64 Million | -120.15 Million | -229.57 Million | -109.42 Million | -258.92 Million | -150.4 Million |
| Interest Expense | - | - | 6.58 Million | - | - | - |
| Income Tax Expense | - | - | -6.03 Million | - | - | - |
| Earnings before Tax | -90.62 Million | -109.01 Million | -243.11 Million | -134.09 Million | -284.15 Million | -140.36 Million |
| Net Income | -90.62 Million | -109.01 Million | -243.11 Million | -134.09 Million | -284.15 Million | -140.36 Million |
| Earnings Per Share Basic | -0.08 | -0.11 | - | -0.13 | - | -0.14 |
| Earnings Per Share Diluted | -0.08 | -0.11 | - | -0.13 | - | -0.14 |
| Weighted Average Shares Outstanding | 1.07 Billion | 1.01 Billion | 1.01 Billion | 1.01 Billion | 991.95 Million | 995.77 Million |
| Weighted Average Shares Outstanding (Diluted) | 1.07 Billion | 1.01 Billion | 1.01 Billion | 1.01 Billion | 991.95 Million | 995.76 Million |
| Gross Margin | 0.76 | 1.00 | 0.31 | 0.89 | 1.00 | 1.00 |
| EBIT Margin | -12.35 | 26.57 | - | -12.06 | - | 41.02 |
| Profit Margin | -14.90 | 26.74 | -178.10 | -15.83 | -70.48 | 40.98 |
| EBITDA | -75.07 Million | -108.33 Million | - | -102.1 Million | - | -140.48 Million |
| Earnings Before Tax Margin | -13.92 | 29.47 | -168.19 | -12.92 | -64.22 | 43.91 |
SEM
600629
6629
SBKFF
TPB
CVLG